scholarly journals Serum S100A8/A9 and S100A12 Levels in Children With Polyarticular Forms of Juvenile Idiopathic Arthritis: Relationship to Maintenance of Clinically Inactive Disease During Anti–Tumor Necrosis Factor Therapy and Occurrence of Disease Flare After Discontinuation of Therapy

2019 ◽  
Vol 71 (3) ◽  
pp. 451-459 ◽  
Author(s):  
Claas H. Hinze ◽  
Dirk Foell ◽  
Anne L. Johnson ◽  
Steven J. Spalding ◽  
Beth S. Gottlieb ◽  
...  
Keyword(s):  
Juvenile Idiopathic Arthritis ◽  
Tumor Necrosis Factor ◽  
Tumor Necrosis ◽  
Inactive Disease ◽  
Disease Flare ◽  
Factor Therapy ◽  
Necrosis Factor

Anti-Interleukin-6 Receptor Tocilizumab for Severe Juvenile Idiopathic Arthritis-Associated Uveitis Refractory to Anti-Tumor Necrosis Factor Therapy: A Multicenter Study of Twenty-Five Patients

2017 ◽  
Vol 69 (3) ◽  
pp. 668-675 ◽  
Author(s):  
Vanesa Calvo-Río ◽  
Montserrat Santos-Gómez ◽  
Inmaculada Calvo ◽  
M. Isabel González-Fernández ◽  
Berta López-Montesinos ◽  
...  
Keyword(s):  
Juvenile Idiopathic Arthritis ◽  
Tumor Necrosis Factor ◽  
Multicenter Study ◽  
Interleukin 6 ◽  
Tumor Necrosis ◽  
Interleukin 6 Receptor ◽  
Factor Therapy ◽  
Necrosis Factor

scholarly journals Genotoxicity of anti–tumor necrosis factor therapy in patients with juvenile idiopathic arthritis

2010 ◽  
Vol 62 (1) ◽  
pp. 73-77 ◽  
Author(s):  
Erkan Demirkaya ◽  
Ismet Cok ◽  
Emre Durmaz ◽  
Onur K. Ulutas ◽  
Nuray Aktay Ayaz ◽  
...  
Keyword(s):  
Juvenile Idiopathic Arthritis ◽  
Tumor Necrosis Factor ◽  
Tumor Necrosis ◽  
Factor Therapy ◽  
Necrosis Factor
Sign in / Sign up

Export Citation Format

Share Document